ABC Arbitrage SA acquired a new position in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 8,625 shares of the company's stock, valued at approximately $1,227,000.
Other hedge funds have also recently made changes to their positions in the company. Elevate Capital Advisors LLC boosted its position in Kimberly-Clark by 46.4% in the 1st quarter. Elevate Capital Advisors LLC now owns 12,444 shares of the company's stock valued at $1,770,000 after buying an additional 3,944 shares during the period. Unigestion Holding SA boosted its position in Kimberly-Clark by 8.2% in the 1st quarter. Unigestion Holding SA now owns 127,623 shares of the company's stock valued at $18,145,000 after buying an additional 9,643 shares during the period. OVERSEA CHINESE BANKING Corp Ltd boosted its position in Kimberly-Clark by 270.2% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 984,695 shares of the company's stock valued at $140,043,000 after buying an additional 718,720 shares during the period. Farmers Trust Co. boosted its position in Kimberly-Clark by 108.6% in the 1st quarter. Farmers Trust Co. now owns 45,088 shares of the company's stock valued at $6,412,000 after buying an additional 23,472 shares during the period. Finally, United Community Bank boosted its position in Kimberly-Clark by 340.0% in the 1st quarter. United Community Bank now owns 18,518 shares of the company's stock valued at $2,634,000 after buying an additional 14,309 shares during the period. Hedge funds and other institutional investors own 76.29% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have commented on KMB. UBS Group decreased their price target on shares of Kimberly-Clark from $146.00 to $139.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. JPMorgan Chase & Co. raised shares of Kimberly-Clark from an "underweight" rating to a "neutral" rating and lifted their price objective for the stock from $125.00 to $138.00 in a research report on Monday, August 4th. Barclays lifted their price objective on shares of Kimberly-Clark from $134.00 to $139.00 and gave the stock an "equal weight" rating in a research report on Monday, August 4th. Evercore ISI decreased their price objective on shares of Kimberly-Clark from $168.00 to $155.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, Royal Bank Of Canada decreased their price objective on shares of Kimberly-Clark from $165.00 to $162.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $142.70.
Get Our Latest Stock Report on Kimberly-Clark
Kimberly-Clark Stock Performance
NYSE KMB traded down $0.61 during trading on Friday, reaching $136.16. The company's stock had a trading volume of 1,653,983 shares, compared to its average volume of 2,334,250. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80. The firm has a market cap of $45.18 billion, a price-to-earnings ratio of 18.03, a P/E/G ratio of 4.46 and a beta of 0.33. Kimberly-Clark Co. has a twelve month low of $124.10 and a twelve month high of $150.45. The business's fifty day moving average price is $130.81 and its 200-day moving average price is $134.92.
Kimberly-Clark (NYSE:KMB - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $1.92 EPS for the quarter, beating analysts' consensus estimates of $1.67 by $0.25. The company had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.85 billion. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. Kimberly-Clark's quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.96 earnings per share. As a group, analysts anticipate that Kimberly-Clark Co. will post 7.5 EPS for the current fiscal year.
Kimberly-Clark Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 2nd. Shareholders of record on Friday, September 5th will be paid a $1.26 dividend. The ex-dividend date is Friday, September 5th. This represents a $5.04 dividend on an annualized basis and a yield of 3.7%. Kimberly-Clark's payout ratio is currently 69.42%.
Kimberly-Clark Profile
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Stories

Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.